Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,486,246
+$174,573 QoQ
Shares Held
13,727
+1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
#1,882
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALTFEST L J & CO INC holds $37,645,467 across 10 Drug Manufacturers - General names. JNJ ranks #3 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,312 | $18,365,673 | |
| 2 | ABBV |
AbbVie Inc.
|
25,963 | $6,533,329 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
13,727 | $3,486,246 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,355 | $2,358,617 | |
| 5 | AZN |
Astrazeneca PLC
|
10,599 | $2,009,782 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
28,858 | $1,662,797 | |
| 7 | AMGN |
Amgen Inc
|
4,072 | $1,474,552 | |
| 8 | PFE |
Pfizer Inc
|
36,216 | $872,081 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,486,246 | 13,727 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $3,311,673 | 13,548 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,878,881 | 13,911 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,197,382 | 17,244 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $2,066,554 | 13,529 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,294,893 | 13,838 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,907,827 | 13,192 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,372,720 | 14,641 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $2,131,889 | 14,586 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $2,391,358 | 15,117 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $2,480,410 | 15,825 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $2,481,876 | 15,935 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $3,342,179 | 20,192 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,443,015 | 22,213 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $2,906,422 | 16,453 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $2,748,041 | 16,822 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,975,067 | 16,760 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,945,030 | 16,617 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $2,849,512 | 16,657 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $2,678,154 | 16,583 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $2,731,553 | 16,581 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $2,754,670 | 16,761 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $2,633,124 | 16,731 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $2,561,331 | 17,204 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $2,516,292 | 17,893 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $2,816,672 | 21,480 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||